Data as of Apr 17
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 10.50, with a high estimate of 11.50 and a low estimate of 10.00. The median estimate represents a +31.41% increase from the last price of 7.99.
The current consensus among 5 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.